Walker 256 tumour cells increase substance P immunoreactivity locally and modify the properties of the blood–brain barrier during extravasation and brain invasion

Cannabinoids Inhibit HIV-1 Gp120-Mediated Insults in Brain Microvascular Endothelial Cells

(2014) T.-S. Lu et al.   JOURNAL OF IMMUNOLOGY

A substance P antagonist improves outcome when administered 4h after onset of ischaemic stroke

(2011) Renée J. Turner et al.   BRAIN RESEARCH

NK-1 Receptor Antagonists: A New Paradigm in Pharmacological Therapy

(2011) M. Munoz et al.   CURRENT MEDICINAL CHEMISTRY

Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2

(2011) Cristina Mayordomo et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Comparison of in vitro and in vivo approaches to studying brain colonization by breast cancer cells

(2011) M. Lorger et al.   JOURNAL OF NEURO-ONCOLOGY

Transmigration of Melanoma Cells through the Blood-Brain Barrier: Role of Endothelial Tight Junctions and Melanoma-Released Serine Proteases

(2011) Csilla Fazakas et al.   PLoS One

Automatic Nonsubjective Estimation of Antigen Content Visualized by Immunohistochemistry Using Color Deconvolution

(2011) Stephen C. Helps et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Capturing Changes in the Brain Microenvironment during Initial Steps of Breast Cancer Brain Metastasis

(2010) Mihaela Lorger et al.   AMERICAN JOURNAL OF PATHOLOGY

Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer

(2010) P. R. Lockman et al.   CLINICAL CANCER RESEARCH

SR140333 counteracts NK-1 mediated cell proliferation in human breast cancer cell line T47D: a randomized controlled trial

(2010) Wei-Qing Huang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

A Substance P Antagonist Reduces Axonal Injury and Improves Neurologic Outcome When Administered Up to 12 Hours after Traumatic Brain Injury

(2010) James J. Donkin et al.   JOURNAL OF NEUROTRAUMA

The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines

(2010) Miguel Muñoz et al.   LABORATORY INVESTIGATION

Angiotensin-converting enzyme (ACE) inhibitors exacerbate histological damage and motor deficits after experimental traumatic brain injury

(2010) Elizabeth Harford-Wright et al.   NEUROSCIENCE LETTERS

Noninvasive imaging of the functional effects of anti-VEGF therapy on tumor cell extravasation and regional blood volume in an experimental brain metastasis model

(2009) Juan JuanYin et al.   CLINICAL & EXPERIMENTAL METASTASIS

Substance P is Associated with the Development of Brain Edema and Functional Deficits after Traumatic Brain Injury

(2009) James J Donkin et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Real-time imaging reveals the single steps of brain metastasis formation

(2009) Yvonne Kienast et al.   NATURE MEDICINE

The Vascular Basement Membrane as “Soil” in Brain Metastasis

(2009) W. Shawn Carbonell et al.   PLoS One

ELEVATED GLUCOSE AND FATTY ACID LEVELS IMPAIR SUBSTANCE P-INDUCED DERMAL MICROVASCULAR ENDOTHELIAL CELL MIGRATION AND PROLIFERATION IN AN AGAROSE GEL MODEL SYSTEM

(2009) Qiang Wang et al.   SHOCK

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer

(2008) Nancy U. Lin et al.   CANCER

Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

(2008) Nancy U. Lin et al.   JOURNAL OF CLINICAL ONCOLOGY

The NK-1 Receptor Is Expressed in Human Primary Gastric and Colon Adenocarcinomas and Is Involved in the Antitumor Action of L-733,060 and the Mitogenic Action of Substance P on Human Gastrointestinal Cancer Cell Lines

(2008) Marisa Rosso et al.   TUMOR BIOLOGY